These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3307401)

  • 41. Efegatran sulfate as an adjunct to streptokinase versus heparin as an adjunct to tissue plasminogen activator in patients with acute myocardial infarction. ESCALAT Investigators.
    Fung AY; Lorch G; Cambier PA; Hansen D; Titus BG; Martin JS; Lee JJ; Every NR; Hallstrom AP; Stock-Novack D; Scherer J; Weaver WD
    Am Heart J; 1999 Oct; 138(4 Pt 1):696-704. PubMed ID: 10502216
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thrombolysis and myocardial infarction.
    Rovelli F; Mauri F; Roghi A
    Biomed Pharmacother; 1987; 41(8):417-20. PubMed ID: 3330456
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coronary thrombolytic therapy: state of the art.
    Marx M; Levin DC
    AJR Am J Roentgenol; 1986 Jul; 147(1):1-8. PubMed ID: 3521234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative tolerance and complications in a multicentre trial of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Rothbard RL
    Drugs; 1987; 33 Suppl 3():276-8. PubMed ID: 3315606
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands.
    Simoons ML; Serruys PW; vd Brand M; Bär F; de Zwaan C; Res J; Verheugt FW; Krauss XH; Remme WJ; Vermeer F
    Lancet; 1985 Sep; 2(8455):578-82. PubMed ID: 2863596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Direct thrombin inhibition and thrombolytic therapy: rationale for the Hirulog and Early Reperfusion/Occlusion (HERO-2) trial.
    White HD
    Am J Cardiol; 1998 Oct; 82(8B):57P-62P. PubMed ID: 9809893
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Aspirin and heparin in the fibrinolytic treatment of acute myocardial infarction].
    López Bescós L
    Rev Esp Cardiol; 1992; 45 Suppl 2():21-8. PubMed ID: 1475505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. International Joint Efficacy Comparison of Thrombolytics.
    Lancet; 1995 Aug; 346(8971):329-36. PubMed ID: 7623530
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Percutaneous transluminal coronary angioplasty during acute myocardial infarction.
    Remetz MS; Cleman MW
    Cardiol Clin; 1988 Feb; 6(1):139-52. PubMed ID: 2971441
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of 2 intravenous thrombolytic agents (anisoylated plasminogen streptokinase activator complex versus streptokinase) in patients with acute myocardial infarction.
    Seabra-Gomes R; Aniceto Silva J; Aleixo A; Real T; Freire I; Torres I; Freitas R; Crespo F
    Drugs; 1987; 33 Suppl 3():169-74. PubMed ID: 3315586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Thrombolysis in acute myocardial infarct: prerequisites, current experiences and remaining problems].
    Rapold HJ
    Schweiz Med Wochenschr; 1986 Aug; 116(33):1074-87. PubMed ID: 3094141
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Medical therapy of acute myocardial infarction: Part I. Role of thrombolytic and antithrombotic therapy.
    Jafri SM; Walters BL; Borzak S
    J Intensive Care Med; 1995; 10(2):54-63. PubMed ID: 10172420
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of thrombolytic regimen, early catheterization, and predischarge angiographic variables on six-week left ventricular function. The TAMI Investigators. Thrombolysis and Angioplasty in Acute Myocardial Infarction.
    Ward SR; Sutton JM; Pieper KS; Schwaiger M; Califf RM; Topol EJ
    Am J Cardiol; 1997 Mar; 79(5):539-44. PubMed ID: 9068505
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thrombolytic therapy and acute myocardial infarction.
    Vandenbogaerde JF
    Biomed Pharmacother; 1989; 43(2):79-85. PubMed ID: 2660919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
    Labinaz M; Sketch MH; Stebbins AL; DeFranco AC; Holmes DR; Kleiman NS; Betriu A; Rutsch WR; Vahanian A; Topol EJ; Califf RM
    Am J Cardiol; 1996 Dec; 78(12):1338-44. PubMed ID: 8970403
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction.
    Zijlstra F; Hoorntje JC; de Boer MJ; Reiffers S; Miedema K; Ottervanger JP; van 't Hof AW; Suryapranata H
    N Engl J Med; 1999 Nov; 341(19):1413-9. PubMed ID: 10547403
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Journal club: thrombolytic agents in the treatment of myocardial infarction.
    Werman HA; Decker GP; Rund DA
    Am J Emerg Med; 1986 Mar; 4(2):181-8. PubMed ID: 3081018
    [No Abstract]   [Full Text] [Related]  

  • 58. High-dose, brief intravenous streptokinase early in acute myocardial infarction.
    Spann JF; Sherry S; Carabello BA; Mann RH; McCann WD; Gault JH; Gentzler RD; Rosenberg KM; Maurer AH; Denenberg BS; Warner HF; Rubin RN; Malmud LS; Comerota A
    Am Heart J; 1982 Oct; 104(4 Pt 2):939-45. PubMed ID: 6751060
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy.
    Mahaffey KW; Granger CB; Collins R; O'Connor CM; Ohman EM; Bleich SD; Col JJ; Califf RM
    Am J Cardiol; 1996 Mar; 77(8):551-6. PubMed ID: 8610601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early versus late hospital arrival for acute myocardial infarction in the western Washington thrombolytic therapy trials.
    Maynard C; Althouse R; Olsufka M; Ritchie JL; Davis KB; Kennedy JW
    Am J Cardiol; 1989 Jun; 63(18):1296-300. PubMed ID: 2499171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.